MERZ on the Move: Days After Ulthera Acquisition, Company Announces Plans for New Retinoid Therapy
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
In this podcast episode, Dr Alex Zuriarrain is back to talk about the surgical and non-surgical neck lift options, who’s a good candidate for what, and setting realistic expectations with your patients.